Literature DB >> 8756628

A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9.

J B Demoulin1, C Uyttenhove, E Van Roost, B DeLestré, D Donckers, J Van Snick, J C Renauld.   

Abstract

Interleukin-9 (IL-9), a T-cell-derived cytokine, interacts with a specific receptor associated with the IL-2 receptor gamma chain. In this report, we analyze the functional domains of the human IL-9 receptor transfected into mouse lymphoid cell lines. Three different functions were examined: growth stimulation in factor-dependent pro-B Ba/F3 cells, protection against dexamethasone-induced apoptosis, and Ly-6A2 induction in BW5147 lymphoma cells. The results indicated that a single tyrosine, at position 116 in the cytoplasmic domain, was required for all three activities. In addition, we observed that human IL-9 reduced the proliferation rate of transfected BW5147 cells, an effect also dependent on the same tyrosine. This amino acid was necessary for IL-9-mediated tyrosine phosphorylation of the receptor and for STAT activation but not for IRS-2/4PS activation or for JAK1 phosphorylation, which depended on a domain closer to the plasma membrane. We also showed that JAK1 was constitutively associated with the IL-9 receptor. Activated STAT complexes induced by IL-9 were found to contain STAT1, STAT3, and STAT5 transcription factors. Moreover, sequence homologies between human IL-9 receptor tyrosine 116 and tyrosines (of other receptors activating STAT3 and STAT5 were observed. Taken together, these data indicate that a single tyrosine of the IL-9 receptor, required for activation of three different STAT proteins, is necessary for distinct activities of this cytokine, including proliferative responses.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8756628      PMCID: PMC231471          DOI: 10.1128/MCB.16.9.4710

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  38 in total

1.  pEF-BOS, a powerful mammalian expression vector.

Authors:  S Mizushima; S Nagata
Journal:  Nucleic Acids Res       Date:  1990-09-11       Impact factor: 16.971

2.  Functional and biochemical characterization of mouse P40/IL-9 receptors.

Authors:  C Druez; P Coulie; C Uyttenhove; J Van Snick
Journal:  J Immunol       Date:  1990-10-15       Impact factor: 5.422

3.  Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family.

Authors:  M Murakami; M Narazaki; M Hibi; H Yawata; K Yasukawa; M Hamaguchi; T Taga; T Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

Review 4.  Interleukin-9.

Authors:  J C Renauld; F Houssiau; J Louahed; A Vink; J Van Snick; C Uyttenhove
Journal:  Adv Immunol       Date:  1993       Impact factor: 3.543

5.  Thymic lymphomas in interleukin 9 transgenic mice.

Authors:  J C Renauld; N van der Lugt; A Vink; M van Roon; C Godfraind; G Warnier; H Merz; A Feller; A Berns; J Van Snick
Journal:  Oncogene       Date:  1994-05       Impact factor: 9.867

6.  Expression cloning of the murine and human interleukin 9 receptor cDNAs.

Authors:  J C Renauld; C Druez; A Kermouni; F Houssiau; C Uyttenhove; E Van Roost; J Van Snick
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

7.  Human T cell lines and clones respond to IL-9.

Authors:  F A Houssiau; J C Renauld; M Stevens; F Lehmann; B Lethe; P G Coulie; J Van Snick
Journal:  J Immunol       Date:  1993-04-01       Impact factor: 5.422

8.  Interleukin-9 stimulates in vitro growth of mouse thymic lymphomas.

Authors:  A Vink; J C Renauld; G Warnier; J Van Snick
Journal:  Eur J Immunol       Date:  1993-05       Impact factor: 5.532

9.  Identification of an essential region for growth signal transduction in the cytoplasmic domain of the human interleukin-4 receptor.

Authors:  N Harada; G Yang; A Miyajima; M Howard
Journal:  J Biol Chem       Date:  1992-11-15       Impact factor: 5.157

10.  Interleukin 9 is expressed by primary and cultured Hodgkin and Reed-Sternberg cells.

Authors:  H J Gruss; M A Brach; H G Drexler; K J Bross; F Herrmann
Journal:  Cancer Res       Date:  1992-02-15       Impact factor: 12.701

View more
  48 in total

1.  Neutralization of interleukin-9 ameliorates symptoms of experimental autoimmune myasthenia gravis in rats by decreasing effector T cells and altering humoral responses.

Authors:  Xiuhua Yao; Qingfei Kong; Xiaoli Xie; Jinghua Wang; Na Li; Yumei Liu; Bo Sun; Ying Li; Guangyou Wang; Wenjin Li; Siying Qu; Haijun Zhao; Dandan Wang; Xijun Liu; Yao Zhang; Lili Mu; Hulun Li
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

Review 2.  Discovery and initial characterization of Th9 cells: the early years.

Authors:  Edgar Schmitt; Tobias Bopp
Journal:  Semin Immunopathol       Date:  2016-11-28       Impact factor: 9.623

Review 3.  The molecular details of cytokine signaling via the JAK/STAT pathway.

Authors:  Rhiannon Morris; Nadia J Kershaw; Jeffrey J Babon
Journal:  Protein Sci       Date:  2018-12       Impact factor: 6.725

4.  IL-9 is important for T-cell activation and differentiation in autoimmune inflammation of the central nervous system.

Authors:  Hongmei Li; Bardia Nourbakhsh; Melissa Cullimore; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  Eur J Immunol       Date:  2011-07-06       Impact factor: 5.532

5.  14-3-3zeta interacts with the alpha-chain of human interleukin 9 receptor.

Authors:  D Sliva; M Gu; Y X Zhu; J Chen; S Tsai; X Du; Y C Yang
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

6.  Improved Total-Body Irradiation Survival by Delivery of Two Radiation Mitigators that Target Distinct Cell Death Pathways.

Authors:  Justin Steinman; Michael Epperly; Wen Hou; John Willis; Hong Wang; Renee Fisher; Bing Liu; Ivet Bahar; Travis McCaw; Valerian Kagan; Hulya Bayir; Jian Yu; Peter Wipf; Song Li; M Saiful Huq; Joel S Greenberger
Journal:  Radiat Res       Date:  2017-11-15       Impact factor: 2.841

7.  Cloning and functional testing of rhesus macaque (Macaca mulatta) IL-9 and IL-33.

Authors:  Sanghita Sarkar; Ann J Hessell; Nancy L Haigwood; James J Kobie
Journal:  J Med Primatol       Date:  2020-02-04       Impact factor: 0.667

8.  IL-9 induces CCL11 expression via STAT3 signalling in human airway smooth muscle cells.

Authors:  Akira Yamasaki; Ali Saleh; Latifa Koussih; Shigeo Muro; Andrew J Halayko; Abdelilah S Gounni
Journal:  PLoS One       Date:  2010-02-12       Impact factor: 3.240

9.  Site-directed mutagenesis reveals a unique requirement for tyrosine residues in IL-7Ralpha and TSLPR cytoplasmic domains in TSLP-dependent cell proliferation.

Authors:  Jun Zhong; Akhilesh Pandey
Journal:  BMC Immunol       Date:  2010-02-08       Impact factor: 3.615

10.  Identification of canonical tyrosine-dependent and non-canonical tyrosine-independent STAT3 activation sites in the intracellular domain of the interleukin 23 receptor.

Authors:  Doreen M Floss; Simone Mrotzek; Tobias Klöcker; Jutta Schröder; Joachim Grötzinger; Stefan Rose-John; Jürgen Scheller
Journal:  J Biol Chem       Date:  2013-05-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.